The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

The test measures the concentration of potassium in the blood to assess overall potassium status.

No, fasting is not typically required for this test.

Causes include inadequate dietary intake, excessive losses (e.g., through vomiting or diarrhea), or certain medications.

Yes, high levels can be life-threatening, requiring immediate medical attention and treatment.

A blood sample is taken from a vein, usually in the arm, and analyzed in a laboratory.

It assesses kidney function and helps diagnose conditions like kidney disease.

Typically, fasting is not necessary, but informing your healthcare provider about medications and recent illnesses is essential.

It provides crucial information about kidney health, aiding in diagnosis, treatment, and monitoring of kidney-related conditions.

Results are usually available within a day, allowing for prompt medical decisions based on kidney function assessment.